Skip to main content
Sai Life Sciences Limited logo

Sai Life Sciences Limited — Investor Relations & Filings

Ticker · SAILIFE ISIN · INE570L01029 LEI · 335800JBS3NY25NIBC93 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 235 across all filing types
Latest filing 2025-02-06 Regulatory Filings
Country IN India
Listing BSE.NS SAILIFE

About Sai Life Sciences Limited

https://www.sailife.com

Sai Life Sciences Limited is a full-service Contract Research, Development, and Manufacturing Organization (CRO-CDMO) that partners with global pharmaceutical and biotechnology innovators to accelerate the discovery, development, and commercialization of complex small molecules. The company provides an integrated platform of services spanning discovery chemistry and biology, DMPK, toxicology, process development, analytical R&D, and commercial-scale manufacturing. With a focus on operational excellence and regulatory compliance, it operates state-of-the-art R&D and manufacturing facilities. Its value proposition centers on the Sai Nxt initiative, which emphasizes investments in advanced technologies, expanded capacity, and a global delivery model designed to reduce time-to-market for novel therapeutics.

Recent filings

Filing Released Lang Actions
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the statement of deviation or variation in the utilization of funds raised through an IPO for the quarter ended 31 December 2024. It references compliance with SEBI regulations and mentions that the statement was reviewed by the Audit Committee. The document is short (2132 characters) and primarily serves as an announcement or confirmation about the use of IPO proceeds, not a detailed financial report or audit. It does not contain financial statements or detailed analysis but is a regulatory compliance disclosure related to IPO fund utilization. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-06 English
Integrated Filing- Financial
Regulatory Filings
2025-02-06 English
Financial Result Updates
Regulatory Filings
2025-02-06 English
Outcome of Board Meeting
Regulatory Filings
2025-02-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation to stock exchanges about the schedule of an earnings conference call for Sai Life Sciences Limited. It mentions the date and time of the call, the dial-in details, and the management representatives who will participate. The document does not contain any financial results or substantive financial data itself, but rather announces the upcoming earnings call event where such information will be discussed. The document length is 4283 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript (CT) announcement or invitation, but since it is only the announcement of the call and not the transcript itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the earnings call schedule under SEBI regulations.
2025-02-03 English
Capacity addition
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding a proposed capacity addition by Sai Life Sciences Limited. It references compliance with SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content details the proposed capacity addition, investment amount, mode of financing, and expected operational timeline. The document is short (2576 characters) and serves as an announcement of a corporate development rather than a financial report or detailed analysis. It does not contain financial statements, audit information, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and disclosures that do not fit other specific categories.
2025-01-25 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.